A specific production-site development theme involving the development of the Second Formulation Building at the Ibaraki Plant, and the completion and commissioning of manufacturing equipment and a new line for powdered dialysate for artificial kidneys. Includes progress from completion and commissioning in 2016 through completion of the new line expansion in 2024.